Scotts Miracle-gro CO Form 4 insider transactions
NYSE
Form 4: Scotts Miracle-Gro Director Stephen L. Johnson Reports Acquisition of Dividend Equivalent Rights
Director Stephen L. Johnson reports acquiring dividend equivalent rights related to Scotts Miracle-Gro common shares.
NYSE
Director Edith Aviles reports acquiring dividend equivalent rights tied to Scotts Miracle-Gro common shares.
NYSE
Director John R. Vines reports acquiring dividend equivalent rights related to Scotts Miracle-Gro shares.
NYSE
Form 4: Scotts Miracle-Gro Director Mark D. Kingdon Reports Acquisition of Dividend Equivalent Rights
Director Mark D. Kingdon reports acquiring dividend equivalent rights tied to Scotts Miracle-Gro common shares.
NYSE
Form 4: Scotts Miracle-Gro Executive Julie DeMuesy Reports Acquisition of Dividend Equivalent Rights
Julie DeMuesy, SVP and Chief HR Officer of Scotts Miracle-Gro, reports acquiring 37 dividend equivalent rights related to existing DSU or RSU grants.
NYSE
Form 4: Scotts Miracle-Gro Director Thomas N. Kelly Jr. Reports Acquisition of Dividend Equivalent Rights
Director Thomas N. Kelly Jr. reports acquiring 80 dividend equivalent rights related to Scotts Miracle-Gro shares.
NYSE
Form 4: Scotts Miracle-Gro Director Brian E. Sandoval Reports Acquisition of Dividend Equivalent Rights
Director Brian E. Sandoval reports acquiring dividend equivalent rights tied to Scotts Miracle-Gro common shares.
NYSE
Director Peter Shumlin reported acquiring 128 dividend equivalent rights in Scotts Miracle-Gro Co on June 7, 2024.
NYSE
Katherine Hagedorn Littlefield, a director of Scotts Miracle-Gro, reported acquiring 17 dividend equivalent rights on June 7, 2024.
NYSE
Nathan Eric Baxter, EVP and COO of Scotts Miracle-Gro, reports acquiring common shares at $56.69 per share on April 25, 2024.
NYSE
Christopher Hagedorn, Division President at Scotts Miracle-Gro, recently acquired additional common shares of the company.
NYSE
James Hagedorn, Chairman, CEO, and President of Scotts Miracle-Gro, reports changes in beneficial ownership of company stock, including acquisitions of common shares and phantom stock.
NYSE
Hagedorn Partnership, along with several insiders including James Hagedorn (Chairman, CEO and President) and Nathan Baxter (EVP and COO), sold common shares of Scotts Miracle-Gro Co (SMG) between May 7th and May 8th, 2024.
NYSE
Nathan Eric Baxter, EVP and COO of Scotts Miracle-Gro, reported the disposal of 1,655 common shares on April 28, 2024, to cover tax obligations.
NYSE
James Hagedorn, Chairman, CEO, and President of Scotts Miracle-Gro, reports acquiring phantom stock representing the right to receive common shares or their cash value.
NYSE
James Hagedorn, Chairman, CEO, and President of Scotts Miracle-Gro, reports transactions involving the company's common shares.
NYSE
Christopher Hagedorn, Division President at Scotts Miracle-Gro, reports acquiring common shares on March 25, 2024.
NYSE
Nathan Eric Baxter, EVP and COO of Scotts Miracle-Gro, reports the acquisition and disposal of common shares on March 25, 2024.
NYSE
Director Brian E. Sandoval increased his holdings in Scotts Miracle-Gro by acquiring 461 common shares in lieu of a cash retainer on April 1, 2024.
NYSE
Stephen L. Johnson, a director at Scotts Miracle-Gro, acquired 461 common shares in lieu of a cash retainer on April 1, 2024.
NYSE
Director Peter Shumlin increased his holdings in Scotts Miracle-Gro through the acquisition of common shares in lieu of a cash retainer.
NYSE
James Hagedorn, Chairman, CEO, and President of Scotts Miracle-Gro, reports acquiring phantom stock representing the right to receive common shares or their cash value.
NYSE
Form 4: Scotts Miracle-Gro Executive Julie DeMuesy Reports Acquisition of Dividend Equivalent Rights
Julie DeMuesy, SVP, CHIEF HR OFFICER of Scotts Miracle-Gro, reports acquiring 37 dividend equivalent rights related to existing DSU or RSU grants.
NYSE
Mark D. Kingdon, a director of Scotts Miracle-Gro, acquired dividend equivalent rights corresponding to 52 common shares on March 8, 2024.
NYSE
Form 4: Scotts Miracle-Gro Director David C. Evans Reports Acquisition of Dividend Equivalent Rights
Director David C. Evans reports acquiring 80 dividend equivalent rights related to existing DSU or RSU grants.
NYSE
Nathan Eric Baxter, EVP and COO of Scotts Miracle-Gro, reports acquiring common shares in two transactions on February 23, 2024, and March 8, 2024.
NYSE
Director John R. Vines reports the acquisition of dividend equivalent rights related to Scotts Miracle-Gro Co shares.
NYSE
Form 4: Scotts Miracle-Gro Director Stephen L. Johnson Reports Acquisition of Dividend Equivalent Rights
Director Stephen L. Johnson reports acquiring dividend equivalent rights convertible to 86 common shares of Scotts Miracle-Gro on March 8, 2024.
NYSE
Thomas N. Kelly Jr., a director at Scotts Miracle-Gro, acquired 80 dividend equivalent rights on March 8, 2024, linked to existing DSU or RSU grants.
NYSE
Director Edith Aviles reports acquiring dividend equivalent rights convertible to 63 common shares of Scotts Miracle-Gro Co on March 8, 2024.